Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.

LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
PRO-QUETIAPINE | PRO DOC LIMITEE | Resolved | 25MG | Updated Report | 2025-03-15 | 247812 |
SODIUM CHLORIDE INJECTION USP | ICU MEDICAL CANADA INC | Actual shortage | 9MG | Updated Report | 2025-03-15 | 251160 |
!!T3 ONCASPAR | SERVIER CANADA INC | Actual shortage | 750UNIT | Updated Report | 2025-03-15 | 241135 |
ORILISSA | ABBVIE CORPORATION | Resolved | 200MG | Updated Report | 2025-03-15 | 245420 |
VENTOLIN DISKUS | GLAXOSMITHKLINE INC | Anticipated shortage | 200MCG | New Report | 2025-03-14 | 252627 |
FLOVENT DISKUS | GLAXOSMITHKLINE INC | Anticipated shortage | 100MCG | New Report | 2025-03-14 | 252624 |
APO-FLUOXETINE | APOTEX INC | Resolved | 10MG | Updated Report | 2025-03-14 | 245456 |
APO-FLUOXETINE | APOTEX INC | Resolved | 20MG | Updated Report | 2025-03-14 | 245459 |
APO-CANDESARTAN TABLETS | APOTEX INC | Resolved | 8MG | Updated Report | 2025-03-14 | 249077 |
APO-NAPROXEN | APOTEX INC | Resolved | 500MG | Updated Report | 2025-03-14 | 248489 |
APO-MELOXICAM | APOTEX INC | Actual shortage | 1.5G | Updated Report | 2025-03-14 | 236240 |
APO-VALACYCLOVIR | APOTEX INC | Resolved | 1000MG | Updated Report | 2025-03-14 | 227714 |
PRO-AAS EC - 80 | PRO DOC LIMITEE | Actual shortage | 80MG | Updated Report | 2025-03-14 | 227097 |
PRAMIPEXOLE | PRO DOC LIMITEE | Actual shortage | 1.5MG | Updated Report | 2025-03-14 | 251799 |
POSANOL | MERCK CANADA INC | Avoided shortage | 200MG | Updated Report | 2025-03-14 | 250614 |
APO-NAPROXEN | APOTEX INC | Resolved | 500MG | Updated Report | 2025-03-14 | 252148 |
APO-DORZO-TIMOP | APOTEX INC | Actual shortage | 5MG 20MG | Updated Report | 2025-03-14 | 249755 |
LONITEN 10MG | PFIZER CANADA ULC | Actual shortage | 10MG | Updated Report | 2025-03-14 | 251155 |
BEYFORTUS | SANOFI PASTEUR LIMITED | Resolved | 50MG | Updated Report | 2025-03-14 | 248064 |
ROPIVACAINE HYDROCHLORIDE INJECTION, USP | FRESENIUS KABI CANADA LTD | Actual shortage | 2MG | Updated Report | 2025-03-14 | 252534 |
CALCIMAR | SANOFI-AVENTIS CANADA INC | Anticipated shortage | 200UNIT | Updated Report | 2025-03-13 | 252590 |
TEVA-METFORMIN | TEVA CANADA LIMITED | Actual shortage | 500MG | New Report | 2025-03-13 | 252587 |
TEVA-TOPIRAMATE | TEVA CANADA LIMITED | Actual shortage | 100MG | New Report | 2025-03-13 | 252584 |
TEVA-RAMIPRIL | TEVA CANADA LIMITED | Actual shortage | 10MG | New Report | 2025-03-13 | 252581 |
TEVA-RAMIPRIL | TEVA CANADA LIMITED | Actual shortage | 5MG | New Report | 2025-03-13 | 252578 |
TEVA-ESCITALOPRAM | TEVA CANADA LIMITED | Resolved | 20MG | Updated Report | 2025-03-13 | 246107 |
TEVA-GABAPENTIN | TEVA CANADA LIMITED | Avoided shortage | 800MG | Updated Report | 2025-03-13 | 249201 |
TEVA-BUSPIRONE | TEVA CANADA LIMITED | Resolved | 10MG | Updated Report | 2025-03-13 | 226174 |
TEVA-5 ASA | TEVA CANADA LIMITED | Resolved | 400MG | Updated Report | 2025-03-13 | 245601 |
TEVA-TOPISONE | TEVA CANADA LIMITED | Resolved | 0.05% | Updated Report | 2025-03-13 | 246098 |
TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Actual shortage | 150MG | Updated Report | 2025-03-13 | 240060 |
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | APOTEX INC | Actual shortage | 1000MG 50MG | Updated Report | 2025-03-13 | 252564 |
APO-ACYCLOVIR OINTMENT | APOTEX INC | Actual shortage | 5% | New Report | 2025-03-13 | 252560 |
TEVA-LACOSAMIDE | TEVA CANADA LIMITED | Actual shortage | 200MG | Updated Report | 2025-03-13 | 247935 |
APO-ATENOL TAB 100MG | APOTEX INC | Actual shortage | 100MG | Updated Report | 2025-03-13 | 252554 |
TEVA-BUDESONIDE | TEVA CANADA LIMITED | Actual shortage | 0.5MG | Updated Report | 2025-03-13 | 195478 |
APO-HYDROXYQUINE | APOTEX INC | Actual shortage | 200MG | New Report | 2025-03-13 | 252548 |
TEVA-BUDESONIDE | TEVA CANADA LIMITED | Actual shortage | 0.125MG | Updated Report | 2025-03-13 | 234891 |
TEVA-TOLTERODINE LA | TEVA CANADA LIMITED | Actual shortage | 2MG | Updated Report | 2025-03-13 | 246118 |
TEVA-SOLIFENACIN | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2025-03-13 | 236376 |
TEVA-QUETIAPINE XR | TEVA CANADA LIMITED | Actual shortage | 150MG | Updated Report | 2025-03-13 | 250906 |
TREANDA | TEVA CANADA LIMITED | Actual shortage | 100MG | Updated Report | 2025-03-13 | 244075 |
TEVA-CANDESARTAN | TEVA CANADA LIMITED | Actual shortage | 16MG | Updated Report | 2025-03-13 | 240519 |
APO-ARIPIPRAZOLE | APOTEX INC | Actual shortage | 5MG | Updated Report | 2025-03-13 | 250322 |
FENTANYL CITRATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Anticipated shortage | 50MCG | Updated Report | 2025-03-13 | 252529 |
TEVA-DONEPEZIL | TEVA CANADA LIMITED | Actual shortage | 5MG | Updated Report | 2025-03-13 | 249207 |
TEVA-CITALOPRAM | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2025-03-13 | 252081 |
TEVA-OLANZAPINE | TEVA CANADA LIMITED | Actual shortage | 10MG | Updated Report | 2025-03-13 | 250390 |
TEVA-LEVETIRACETAM | TEVA CANADA LIMITED | Actual shortage | 250MG | Updated Report | 2025-03-13 | 250903 |
TEVA-SUMATRIPTAN | TEVA CANADA LIMITED | Actual shortage | 100MG | Updated Report | 2025-03-13 | 252078 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
BETOPTIC S | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 0.25% | New Report | 2025-03-11 | 252361 |
PAXIL TAB 10MG | GLAXOSMITHKLINE INC | To be discontinued | 10MG | Updated Report | 2025-03-07 | 224405 |
DEXTROSE INJECTION USP | ICU MEDICAL CANADA INC | Discontinued | 200MG | Updated Report | 2025-02-20 | 233049 |
STERILE WATER FOR INJECTION USP | ICU MEDICAL CANADA INC | Discontinued | 100% | Updated Report | 2025-02-20 | 199997 |
SODIUM CHLORIDE INJECTION USP | ICU MEDICAL CANADA INC | Discontinued | 4.5MG | Updated Report | 2025-02-20 | 246144 |
TROSEC | SUNOVION PHARMACEUTICALS CANADA INC | To be discontinued | 20MG | Updated Report | 2025-02-10 | 250062 |
KIVEXA | VIIV HEALTHCARE ULC | To be discontinued | 300MG 600MG | Updated Report | 2025-02-07 | 238375 |
CASODEX | ASTRAZENECA CANADA INC | Discontinued | 50MG | Updated Report | 2025-02-07 | 231878 |
SKYRIZI | ABBVIE CORPORATION | Discontinued | 75MG | Updated Report | 2025-02-06 | 248607 |
NUTROPIN AQ NUSPIN 5 | HOFFMANN-LA ROCHE LIMITED | Discontinued | 5MG | Updated Report | 2025-02-01 | 232071 |